Browse > Article

Effects of Hydroxyl Group Numbers on the B-Ring of 5,7-Dihydroxyflavones on the Differential Inhibition of Human CYP 1A and CYP1B1 Enzymes  

Kim Hyun-Jung (School of Life Sciences and Biotechnology, Korea University)
Lee Sang Bum (School of Life Sciences and Biotechnology, Korea University)
Park Song-Kyu (Korea Research Institute of Bioscience and Biotechnology)
Kim Hwan Mook (Korea Research Institute of Bioscience and Biotechnology)
Park Young In (School of Life Sciences and Biotechnology, Korea University)
Dong Mi-Sook (School of Life Sciences and Biotechnology, Korea University)
Publication Information
Archives of Pharmacal Research / v.28, no.10, 2005 , pp. 1114-1121 More about this Journal
Abstract
Flavonoids are polyphenols composed of two aromatic rings (A, B) and a heterocyclic ring (C). In order to determine the effects of the number of hydroxyl groups in the B-ring of the flavonoids on human cytochrome P450 (CYP) 1 family enzymes, we evaluated the inhibition of CYP1A-dependent 7-ethoxyresorufin O-deethylation activity by chrysin, apigenin and luteolin, using bacterial membranes that co-express human CYP1A1, CYP1A2, or CYP1B1 with human NADPH-cytochrome P450 reductase. Chrysin, which possesses no hydroxyl groups in its B-ring, exhibited the most pronounced inhibitory effects on CYP1A2-dependent EROD activity, followed by apigenin and luteolin. On the contrary, CYP1A1-mediated EROD activity was most potently inhibited by luteolin, which is characterized by two hydroxyl groups in its B-ring, followed by apigenin and chrysin. However, all of the 5,7-dihydroxyflavones were determined to similarly inhibit CYP1B1 activity. Chrysin, apigenin, and luteolin exhibited a mixed-type mode of inhibition with regard to CYP1A2, CYP1B1, and CYP1A1, with apparent Ki values of 2.4, 0.5, and 2.0 ${\mu}M$, respectively. These findings suggested that the number of hydroxyl groups in the B-ring of 5,7-dihydroxyflavone might have some influence on the degree to which CYP1A enzymes were inhibited, but not on the degree to which CYP1B1 enzymes were inhibited.
Keywords
CYP1 enzymes; Ethoxyresorufin O-deethylase; Chrysin; Apigenin; Luteolin;
Citations & Related Records

Times Cited By Web Of Science : 14  (Related Records In Web of Science)
Times Cited By SCOPUS : 13
연도 인용수 순위
1 Dai, R., Zhai, S., Wei, X., Pincus, M. R., Vestal, R. E., and Friedman, F. K., Inhibition of human cytochrome P4501A2 by f1avones: a molecular modeling study. J. Protein Chem., 17, 643-650 (1998)   DOI   ScienceOn
2 Guengerich, F. P. and Shimada, T., Activation of procarcinogens by human cytochrome P450 enzymes. Mutat. Res., 400, 201-213 (1998)   DOI   ScienceOn
3 Lautraite, S., Musonda, A. C., Doehmer, J., Edwards, G.O., and Chipman, J. K., Flavonoids inhibit qenetic toxicity produced by carcinogens in cells expressinq CYP1A2 and CYP1A1. Mutagenesis, 17, 45-53 (2002)   DOI   ScienceOn
4 Ross, J. A. and Kasum, C. M., Dietary f1avonoids: bioavailability, metabolic effects and safety. Annu. Rev. Nutr., 22, 19-34 (2002)   DOI   ScienceOn
5 Yasukochi, Y. and Masters, B. S. S., Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P450): Reductase purified by biospecific affinity chromatography. J. Biol. Chem., 251, 5337-5344 (1976)
6 Parikh, A., Gillam, E. M. J., and Guengerich, F. P., Drug meta-bolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol., 15, 784-788 (1997)   DOI   ScienceOn
7 So, F. V., Guthrie, N., Chambers, A. F., Moussa, M., and Carroll, K. K., Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr. Cancer, 26, 167-181 (1996)   DOI   ScienceOn
8 Gonzalez, F. J. and Gelboin, H. V., Role of human cytochrome P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev., 26, 165-183 (1994)   DOI   ScienceOn
9 Breinholt, V. M., Offord, E. A., Brouwer, C., Nielsen, S. E., Brosen, K., and Friedberg, T., In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem. Toxicol., 40, 609-616 (2002)   DOI   ScienceOn
10 Kang, I. H., Kim, H. J., Oh, H., Park, Y. I., and Dong, M.-S., Biphasic effects of the f1avonoids quercetin and naringenin on the metabolic activation of 2-arnino-3,5-dimethylimidazo 4,5-f quinoline by Salmonella typhimurium TA1538 coexpressing human cytochrome P450 1A2, NADPH-cyto-chrome P450 reductase and cytochrome $b_5$. Mutat. Res., 545, 37-47 (2004)   DOI   ScienceOn
11 Hodek, P., Trefil, P., and Stiborova, M., Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chemico-Biological lnteractions, 139, 1-21 (2002)   DOI   ScienceOn
12 Shimada, T., Wunsch, R. M., Hanna, I. H., Sutter, T. R., Guengerich, F. P., and Gillam, E. M. J., Recombinant human cytochrome CYP1B1 expression in Escherichia coli. Arch. Biochem. Biophys., 357, 111-120 (1998)   DOI   ScienceOn
13 Takahashi, E., Fujita, K., Kamataki, T., Arimoto-Kobayashi, S., Okamoto, K., and Negishi, T., Inhibition of human cytochrome P450 1B1, 1A1, and 1A2 by antigenotoxic compounds purpurin and alizarin. Mutat. Res., 508, 147-156 (2002)   DOI   ScienceOn
14 Zhai, S., Dai, R., Friedman, F. K., and Vestal, R. E., Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. Drug Metab. Dispos., 26, 989-992 (1998)
15 Pietta, P. G., Flavonoids as antioxidants. J. Nat. Product, 63, 1035-1042 (2000)   DOI   PUBMED   ScienceOn
16 Rendic, S. and Di Carlo, F. J., Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metab. Rev., 29, 413-580 (1997)   DOI   ScienceOn
17 Kim, J. Y., Lee, S., Kim, D. H., Kim, B. R., Park, R., and Lee, B. M., Effects of f1avonoids isolated from Scutellariae radix on cytochrome P-450 activities in human liver microsomes. J. Toxicol. Environ. Health, 65, 373-381 (2002)   DOI   ScienceOn
18 Lee, H., Yeom, H., Kim, Y. G., Yoon, C. N., Jin, C., Choi, J. S., Kim, B. R., and Kim, D. H., Structure-related inhibition of human hepatic caffeine N3-dernethylation by naturally occurring flavonoids. Biochem. Pharm., 55, 1369-1375 (1998)   DOI   PUBMED   ScienceOn
19 Moon, J. Y., Lee, D. W., and Park, K. H., Inhibition of 7-ethoxycoumarin O-deethylase activity in rat liver microsomes by naturally occurring flavonoids: structure-activity relationships. Xenobiotica, 28, 117-126 (1998)   DOI   PUBMED
20 Guengerich, F. P., Human cytochrome P450 enzymes. In Cytochrome P450: Structure, Mechanism and Biochemistry, 2nd edition, P. R. Ortiz de Montellano (Eds.). Plenum Press, New York, pp. 473-535, (1995)
21 Tanaka, T., Makita, H., Ohnishi, M., Mori, H., Satoh, K., Hara, A., Sumida, T., Fukutani, K., Tanaka, T., and Ogawa, H., Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperedin, each alone and in combination. Cancer Res., 57, 246-252 (1997)
22 Doostdar, H., Burke, M. D., and Mayer, R. T., Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology, 144, 31-38 (2000)   DOI   PUBMED   ScienceOn
23 Dong, M.-S., Chang, S. K., Kim, H. J., Gillam, E. M. J., Guengerich, F. P., and Park, Y. I., Inhibition of 7-alkoxyresorufin O-dealkylation activities of recombinant human CYP1A1 and CYP1B1 by resveratrol. Environ. Mutagen Carcinogens, 22, 169-174 (2002)
24 Kanazawa, K., Yamashita, T., Ashida, H., and Danno, G., Antimutagenicity of f1avones and flavonols to heterocyclic amines by specific and strong inhibition of the cytochrome P450 1A family. Biosci. Biotech. Biochem., 62, 970-977 (1998)   DOI   ScienceOn
25 Frank, A. A., Cooney, R. V., Custer, L. J., Mordan, L. J., and Tanaka, Y., Inhibition of neoplastic transformation and bioavailability of dietary flavonoid agents. Adv. Exp. Med. Biol., 439, 237-248 (1998)
26 Omura, T. and Sato, R., The carbon monoxide-binding pigment of liver microsome. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370-2378 (1964)